MC1R and MC5R agonists reduced anti-inflammatory cytokines and chemokines and enhanced manganese superoxide dismutase and glutathione peroxidase levels of retinal cells, indicating that MC1R and MC5R agonists exert a protective role on experimental diabetic retinopathy [53]. Here, MC5R is linked to diabetic retinopathy.